Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_assertion type Assertion NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_head.
- NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_assertion wasGeneratedBy ECO_0000203 NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_provenance.
- NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_assertion wasDerivedFrom befree-20150227 NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_provenance.
- NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_assertion SIO_000772 18690645 NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_provenance.
- NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_assertion evidence source_evidence_literature NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_provenance.
- NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_assertion description "[The CD44 variants modified by the sialyl Lewis a and sialyl Lewis x glycotopes are expected to have dual functions, serving as ligands for vascular selectins, and simultaneously having binding activity to vascular bed hyaluronate, and are expected to figure heavily in cancer metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414680.RAg3p_l9pdwN0447NH4twIABmlfYLyh8r4hZ7K5BIr57k130_provenance.